Veradigm Inc.
MDRX · OTC
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | – | $0 | $0 | $0 |
| % Growth | – | 0.7% | 5.8% | – |
| Cost of Goods Sold | – | $0 | $0 | $0 |
| Gross Profit | – | $0 | $0 | $0 |
| % Margin | – | 54.9% | 52.7% | 51.5% |
| R&D Expenses | – | $0 | $0 | $0 |
| G&A Expenses | – | $0 | $0 | $0 |
| SG&A Expenses | – | $0 | $0 | $0 |
| Sales & Mktg Exp. | – | $0 | $0 | $0 |
| Other Operating Expenses | – | $0 | $0 | $0 |
| Operating Expenses | – | $0 | $0 | $0 |
| Operating Income | – | $0 | -$0 | $0 |
| % Margin | – | 16.5% | -3.5% | 4.6% |
| Other Income/Exp. Net | – | -$0 | $0 | -$0 |
| Pre-Tax Income | – | $0 | -$0 | $0 |
| Tax Expense | – | $0 | -$0 | -$0 |
| Net Income | – | $0 | -$0 | $0 |
| % Margin | – | 6.2% | -42.4% | 16% |
| EPS | – | 0.13 | 0.028 | 0.17 |
| % Growth | – | 364.3% | -83.5% | – |
| EPS Diluted | – | 0.12 | 0.027 | 0.17 |
| Weighted Avg Shares Out | – | 129 | 114 | 139 |
| Weighted Avg Shares Out Dil | – | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | – | $0 | $0 | $0 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | – | $0 | $0 | $0 |
| EBITDA | – | $0 | $0 | $0 |
| % Margin | – | 26.2% | 7.2% | 14.3% |